Psyence Biomedical Ltd. Common Shares (PBM) — Financial Flexibility Index
Psyence Biomedical Ltd. Common Shares (PBM) has a Financial Flexibility Index of -0.05x as of December 2023. Free cash flow of $-658.20 (operating CF $-662.00 minus capex $3.80) represents 0% of total liabilities ($12.10K). Also explore PBM year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Psyence Biomedical Ltd. Common Shares Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Psyence Biomedical Ltd. Common Shares across 4 annual periods. Check PBM strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Psyence Biomedical Ltd. Common Shares (2022–2025)
Year-by-year free cash flow to debt coverage for Psyence Biomedical Ltd. Common Shares. For the full company profile including market capitalisation, see market value of Psyence Biomedical Ltd. Common Shares.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.27x | $-3.72 Million | $-3.73 Million | $594.37K | ▼ -2480.2% |
| 2024 | -0.24x | $-2.94 Million | $-2.95 Million | $12.10 Million | ▼ -567.0% |
| 2023 | -0.04x | $-519.60K | $-519.60K | $14.27 Million | ▲ +57.3% |
| 2022 | -0.09x | $-1.40 Million | $-1.40 Million | $16.38 Million | — |